Content area

|
|

Mikromiljøet som med- og modspiller i B-celle-non-Hodgkin-lymfomer

Forfatter(e)
Uffe Klausen1, Mads Hald Andersen1 & Lars Møller Pedersen2 1) Center for Cancer Immunterapi, Hæmatologisk Afdeling, Herlev og Gentofte Hospital 2) Hæmatologisk Afdeling, Herlev og Gentofte Hospital Ugeskr Læger 2017;179:V03170220
Reference: 
Ugeskr Læger 2017;179:V03170220
Blad nummer: 
Sidetal: 
2-6
Micro-environment being agonist as well as antagonist in B-cell non-Hodgkin lymphoma pathology
The tumour micro-environment has emerged as an essential component in B-cell non-Hodgkin lymphoma pathology, with both nurturing and protective cells. The diversity and impact of the micro-environment seems to be greater in the indolent lymphoma types, while the aggressive subtypes are more independent. The prognostic impact of the environmental cells seems to depend on the specific treatment, and novel treatments targeting the micro-environment are emerging. Immune checkpoints, expressed by lymphomas, serve as promising targets for immune checkpoint inhibitors and vaccination therapy.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Svend Erik Gundestrup | 15/11
1 Kommentar
af Heidi Ingerslev Jørgensen | 14/11
5 kommentarer
af Peter Tagmose Thomsen | 09/11
1 Kommentar
af Frank Bang Nissen | 09/11
1 Kommentar
af Frank Bang Nissen | 09/11
3 kommentarer
af Klaus Tage Mikal Tobiasen | 05/11
2 kommentarer
af Jørn Rosborg | 05/11
1 Kommentar